| To Be Made Available To 100,000 Participating Investment Advisors BETHESDA, Md., Oct. 25, 2011 /PRNewswire/ -- Northwest Biotherapeutics (OTC.BB: NWBO) (NORTHWEST BIO) today announced initiation of Factual Stock Report coverage in conjunction with Standard & Poor's Market Access Program, an information distribution service that enables subscribing publicly traded companies to have corporate information disseminated to users of Standard & Poor's MarketScope Advisor, used by more than 100,000 in...continued NWBO Healthcare Drugs trials |
Tuesday, October 25, 2011
NORTHWEST BIO Announces Initiation of S&P Coverage, With Publication of First Company Stock Report
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment